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http:WHAT THIS PAPER ADDS
Different ﬂow velocities and haemodynamics have been reported after carotid angioplasty with stenting than
after carotid endarterectomy. Whether or not these changes in ﬂow velocities lead to a higher rate of apparent
restenosis is still not clear. We performed an analysis within randomised data to evaluate the natural pattern of
changes in peak systolic velocities in the internal carotid artery (ICA) following carotid revascularisation. We also
analysed the rate of apparent restenosis with survival analysis and ICA/common carotid artery duplex ratios.Background and purpose: Different ﬂow velocities have been reported after carotid angioplasty with stenting
(CAS) than after carotid endarterectomy (CEA). We compared blood ﬂow velocities following CAS and CEA in the
International Carotid Stenting Study (ICSS; ISRCTN25337470).
Materials and methods: In total, 254 patients (70% male; 129 CAS and 125 CEA) were included. Mean peak
systolic velocities (PSVICA) were assessed at baseline, 30 days, 1 and 2 years. Following both treatments,
restenosis 50% was deﬁned as PSVmean >125 cm s1.
Results: CAS and CEA resulted in a similar reduction in PSVICA 1 month after treatment. Post-intervention analysis
for each treatment separately revealed that PSVICA following CAS increased signiﬁcantly during follow-up (30 days
to 2 years; 22.4 cm s1; 95% conﬁdence interval (CI), 14.3 to 30.5). On the contrary, PSVICA following CEA
remained relatively stable during follow-up (4.7 cm s1; 95% CI, 6.5 to 15.9). When we analysed the increase in
PSVICA between both treatments after 2 years of follow-up, no signiﬁcant interprocedural difference was
observed. The internal carotid artery/common carotid artery (ICA/CCA) PSV ratio increased after CAS but not
after CEA: 1.2 vs. 1.1 (0.04, 95% CI; 0.16 to 0.25) at 30 days; 1.5 vs. 1.1 (0.39, 95% CI; 0.13 to 0.65) at 1 year;
and 1.5 vs. 1.1 (0.36; 95% CI, 0.08 to 0.63) at 2 years. The rate of apparent ipsilateral ICA restenosis >50% was
higher following CAS (hazard ratio 2.35; 95% CI, 1.35 to 4.09).
Conclusion: Two years after carotid revascularisation, no signiﬁcant interprocedural difference was observed in
the increase of PSVICA between CAS and CEA. However, the ICA/CCA ratio increased more following CAS resulting
in an apparent higher rate of restenosis following CAS.
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//dx.doi.org/10.1016/j.ejvs.2013.02.013and stenting (CAS) has been proposed as a minimally invasive
alternative, but was associated with a higher risk of peri-
procedural stroke or death in several randomised trials.2,3 In
addition, data from two randomised trials have suggested
that the rate of recurrent stenosis, as measured with duplex
ultrasound (DUS), is higher after CAS than after CEA.4,5
In both trials, DUS was performed across a wide range of
centres, with the inherent risk of variability in measure-
ments of ﬂow velocity. In the Stent-Protected Angioplasty vs.
Carotid Endarterectomy (SPACE) study, no speciﬁc cut-off
DUS values for recurrent stenosis of the ICA were used
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namic parameters that were established and evaluated
in the local ultrasound labs.4 In the Endarterectomy vs.
Angioplasty in Patients with Symptomatic Severe Carotid
Stenosis (EVA-3S) trial, restenosis of 50e69% was diagnosed
on planimetry, whereas carotid restenosis 70% or occlu-
sion was diagnosed when it was present either on planim-
etry or with velocity parameters.5 In none of these two
trials, differences in ﬂow velocities between the two treat-
ment arms were compared over time.
In patients treated with CEA, there is a good agreement
between grading the severity of carotid stenosis based on the
mean peak ﬂow velocity (PSVICA) as measured with DUS and
grading with digital subtraction angiography.6 However, it has
been suggested that the ratio between PSVs in the ICA and
common carotid artery (CCA), the ICA/CCA ratio, is superior
to the PSVICA in evaluating the degree of stenosis in patients
with symptomatic stenosis, and this ratio has been used to
quantify restenosis during follow-up after CEA.7 For CAS, the
level of agreement and speciﬁc duplex criteria are less clear.8
A study of the suggested differential natural pattern of
PSVICA following carotid revascularisation within a rando-
mised patient cohort (CAS vs. CEA) has, to our knowledge,
never been performed.
We aimed to compare the natural pattern of changes in
PSVICA and ICA/CCA ratio after CAS or CEA in a single institution
within a cohort of patients randomised for the International
Carotid Stenting Study (ICSS) during a follow-up of 2 years. In
addition, we compared the rates of apparent restenosis
between CAS and CEA based on current PSV criteria.METHODS
Patients
All patients in the present study are participants in the
International Carotid Stenting Study (ICSS; ISRCTN25337470)
at the University Medical Center Utrecht, the Netherlands,
enrolled between September 2003 and October 2008. ICSS
is an international multicentre randomised controlled, open,
clinical trial, comparing the risks, beneﬁts and cost-
effectiveness of CAS and CEA in patients with a recently
symptomatic ICA stenosis 50%. Patient criteria, random-
isation and the results of an interim safety analysis have
been described elsewhere.9 Baseline demographic, clinical
and carotid imaging data were collected as part of ICSS.
Randomisation in ICSS was stratiﬁed by centre with mini-
misation for sex, age, contralateral occlusion and side of the
randomised artery. The degree of carotid stenosis was
assessed by DUS in all patients and conﬁrmed with either
computed tomography angiography (CTA) or magnetic
imaging angiography (MRA) prior to enrolment.CEA procedure
A vascular surgeon who had been approved by the
Credentials Committee performed CEA. Shunts or patches
were selectively used as required by the operating surgeon.
In our vascular centre, endarterectomy of the ICA wasperformed using a longitudinal arteriotomy with semiclosed
(blind) endarterectomy in the ECA. Premedication (aspirin,
statin and dipyridamol) was started prior to the procedure
at the outpatient clinic and continued indeﬁnitely following
revascularisation.
CAS procedure
A designated interventionalist performed CAS with percu-
taneous transluminal interventional techniques using
a femoral access. The type of stent and a cerebral protection
device (CPD) were applied at the discretion of the inter-
ventionalist. Premedication (a combination of aspirin, clo-
pidogrel and statin) was prescribed at a minimum 3 days
prior to stenting to cover the period of stenting and for
a minimum of 12 weeks afterwards.
DUS scanning
DUS of both the ipsilateral and the contralateral carotid
artery was performed in a single vascular laboratory before
randomisation and 1 month and 1 and 2 years after treat-
ment (HP/Agilent, Sonos 2500 or 4500, Andover,MA, USA). At
each time point the ipsilateral and contralateral PSVICA of ICA
and CCA (PSVCCA) in all patients were recorded. The PSVICA in
individual patients was obtained by taking the highest PSV
during repeated measurements in the vessel, which was
analysed during DUS. PSVICA stated in the results and tables
reﬂects themean value for the entire group on that particular
time of follow-up. The ICA/CCA ratio reﬂects the PSV ratio
between the ICA and the CCA. The stated ICA/CCA ratio was
themean value of the ratios for all patients in each group.The
current DUS criteria for the ICA used in our vascular labora-
tory are based on the criteria recommended by the American
Society of Radiologists: (<50% stenosis (PSV <125 cm s1);
moderate stenosis, 50e69% (PSV >125e230 cm s1),
signiﬁcant stenosis, 70e99% (PSV >230 cm s1) and occlu-
sion).10 A PSV >125 cm s1 was used as a cut-off point for
a stenosis50% in both procedures. There is no consensus in
accurately grading in-stent restenosis and therefore we used
this cut-off point to compare the natural increase in PSV over
time between both procedures.
Outcome measures
Our primary outcome measure was the interprocedural
change in PSVICA (stated as DPSVICA in the results and
tables, this reﬂects the difference in PSVICA between two
particular times of follow-up) in the ipsilateral ICA following
carotid revascularisation (CAS vs. CEA). The increase in PSV
in both treatments separately was also analysed. Secondary
outcome measures were the ICA/CCA ratios at baseline and
during follow-up and the development of ICA restenosis to
a degree of 50%, applying the same threshold of DUS-
derived PSV >125 cm s1 for both CEA and CAS.
Statistical analysis
We compared differences between treatment groups in
the changes in PSVICA and ICA/CCA ratios with mean
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intervals (CIs) and performed actuarial survival analysis
with KaplaneMeier life tables for the occurrence of
50% restenosis. Cox regression analysis was used to
calculate hazard ratios (HRs). A p-value of <0.05 was
considered statistically signiﬁcant for all analyses. Statis-
tical analysis was performed with Statistical Package for
the Social Sciences (SPSS) version 18 (SPSS Inc, Chicago IL,
USA).RESULTS
Patients and follow-up
A total of 270 patients were enrolled in ICSS at our centre,
of whom 136 were randomised to CAS and 134 to CEA
(Fig. 1). Sixteen patients were excluded from the present
study due to the following reasons: incomplete pre-
interventional DUS (N ¼ 3), ICA occlusion prior to revas-
cularisation (N ¼ 7), death between randomisation and
actual revascularisation (N ¼ 2) or no intervention per-
formed because of recent myocardial infarction (N ¼ 4).
Therefore, in total, 129 CAS and 125 CEA patients remained
for analysis in the present sub-study. There were no
signiﬁcant differences in baseline characteristics or pre-
senting symptoms between the two groups except for more
patients with amaurosis fugax at presentation in the CAS
group (Table 1). During follow-up all 254 patients
completed follow-up at 30 days. Hundred twenty-two
patients randomised to CAS and 115 randomised to CEAFigure 1. Flow-charhad DUS at 1 year, and 110 vs. 100 at 2 years. During the
period of follow-up, 21 patients had died, 5 were lost to
follow-up and 18 were unable to reach the hospital for DUS
due to severe co-morbidity.
Peak systolic velocities
PSVICA in the ipsilateral and contralateral ICA prior to
treatment did not differ between both groups. CAS and CEA
resulted in a similar decrease in the ipsilateral PSV 1 month
after treatment (MD between groups 19.4 cm s1; 95%
CI, 63.7 to 25.0); this difference in PSVICA between the
PSVICA during follow-up and the PSVICA pre-procedurally
(stated as DPSVICA in the table) between both procedures
remained stable during follow-up at 1 year (MD 6.2 cm s1;
95% CI 36.5 to 48.9) and 2 years (MD 22.0 cm s1; 95%
CI 22.2 to 66.2) of follow-up (CAS vs. CEA, Table 2). The
lack of signiﬁcant interprocedural difference between both
procedures was mainly due to a relatively lower PSVICA
following CAS at 30 days of follow-up and a higher post-
procedural PSVICA after 2 years.
When we analysed the increase in following each
treatment separately, DPSVICA following CAS increased
signiﬁcantly (MD between 30 days and 2 years;
22.4 cm s1; 95% CI, 14.3 to 30.5) whereas DPSVICA
following CEA remained relatively stable over time during
follow-up (MD between 30 days and 2 years; 4.7 cm s1;
95% CI, 6.5 to 15.9).
Both CAS and CEA had no effect on the PSVICA in the
contralateral ICA during follow-up.t of follow-up.
Table 1.
Baseline characteristics CAS CEA
N 129 125
Male (%) 68.8 71.2
Age (range) 68.1
(43.0e83.0)
68.2
(42.0e88.0)
Side treated Right (%) 52.7 55.2
Symptoms at
presentation (%)
Retinal infarction 3.2 3.2
TIA 39.5 44.8
Amaurosis fugax 33.3 20.8
Ischaemic stroke 24.0 31.2
Ipsilateral degree
of stenosis (%)
50e69% 9.6 8.5
70e99% 90.4 91.5
Contralateral
degree of
stenosis (%)
0e49% 61.2 55.2
50e69% 11.7 16.0
70e99% 18.6 24.8
Occlusion 8.5 4.0
Diabetes mellitus (%) 20.2 19.2
Treated hypertension (%) 65.9 63.2
Treated hyperlipidaemia (%) 64.3 74.4
Myocardial infarction (%) 14.7 18.4
Atrial ﬁbrillation (%) 4.7 6.4
Previous CABG (%) 9.3 16.0
(History of) smoking (%) 84.5 84.8
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Ipsilateral and contralateral ICA/CCA ratios at baseline did
not differ between the two groups. CAS and CEA resulted in
a similar decrease in ICA/CCA ratio at 30 days (MD between
groups, 0.04; 95% CI, 0.16 to 0.25). However, the ratio
Table 2. Mean PSV ICA ipsi-/contralateral, CAS vs. CEA.
PSVICA (cm/s) Ipsilate
Randomisation N PSVICA
Pre-intervention CAS 129 367 (1
CEA 125 352 (1
30 days follow-up CAS 129 90 (4
CEA 125 94 (7
1 year follow-up CAS 122 107 (5
CEA 115 94 (6
2 years follow-up CAS 110 112 (5
CEA 100 94 (7
PSVICA (cm/s) Contra
Randomisation N PSVICA
Pre-intervention CAS 129 155 (1
CEA 125 162 (1
30 days follow-up CAS 129 139 (1
CEA 125 147 (1
1 year follow-up CAS 122 136 (1
CEA 115 135 (1
2 years follow-up CAS 110 138 (1
CEA 100 142 (1
DPSVICA reﬂects the difference between PSVICA pre-procedurally and Pwas signiﬁcantly lower following CEA compared to CAS after
1 year (MD 0.39; 95% CI, 0.13 to 0.65) and 2 years (MD
0.36; 95% CI, 0.08 to 0.63) of follow-up.
In the contralateral non-treated artery the ICA/CCA ratio
did not change during follow-up (Table 3).
Prevalence of apparent 50% restenosis
KaplaneMeier estimates of the prevalence of apparent
recurrent stenosis 50% of the ipsilateral ICA are shown in
Fig. 2. The prevalence of apparent 50% restenosis using
the same DUS criteria for follow-up after both techniques
was higher following CAS compared to CEA (hazard ratio
(HR) 2.35; 95% CI, 1.35 to 4.09). When we compared the
prevalence of stenosis of 50% in the contralateral ICA the
progression of stenosis following CAS and CEA was similar
(HR 1.02; 95% CI, 0.69 to 1.52 (Fig. 3).
DISCUSSION
This randomised study did not reveal a signiﬁcant inter-
procedural difference in PSVICA between CAS and CEA at
several time points following revascularisation. The lack of
signiﬁcant interprocedural difference between both proce-
dures was mainly due to a relatively lower PSVICA following
CAS at 30 days of follow-up and a higher postprocedural
PSVICA after 2 years. When we analysed the difference in
PSVICA for the two treatments individually to analyse
progression of restenosis following each treatment sepa-
rately (30 days compared to 2 years), we did observe
a signiﬁcant intraprocedural increase in PSVICA following
CAS over this time frame. On the other hand, we found no
signiﬁcant increase in PSVICA following CEA between 30 days
and 2 years. This reﬂects a larger increase in PSVICA
following CAS as compared to CEA.
The PSVICA among patients having CEA was initially higher
when compared to those having CAS suggesting some more
arterial narrowing immediately after surgery. Then, over theral side
(SD) DPSVICA Mean diff. 95% CI
75) N/A N/A N/A
80) N/A
4) 277.6 19.4 (63.7 to 25.0)
2) 258.2
4) 262.0 6.2 (36.5 to 48.9)
5) 268.2
6) 270.8 22.0 (22.2 to 66.2)
2) 292.8
lateral side
(SD) DPSVICA Mean diff. 95% CI
35) N/A N/A N/A
38) N/A
26) 15.5 0.8 (19.2 to 17.5)
36) 14.6
25) 21.5 8.4 (16.1 to 32.8)
10) 29.9
24) 15.0 11.5 (17.8 to 40.9)
26) 26.5
SVICA at time of follow-up.
Table 3. ICA/CCA ratios ipsi-/contralateral, CAS vs. CEA.
ICA/CCA ratios Ipsilateral side
Randomisation N Mean (SD) Mean diff. 95% CI
Pre-intervention CAS 129 5.6 (3.6) 0.03 (1.05 to 1.00)
CEA 125 5.6 (4.7)
30 days follow-up CAS 129 1.2 (0.8) 0.04 (0.16 to 0.25)
CEA 124 1.1 (0.8)
1 year follow-up CAS 121 1.5 (1.2) 0.39 (0.13 to 0.65)
CEA 113 1.1 (0.8)
2 years follow-up CAS 108 1.5 (0.9) 0.36 (0.08 to 0.63)
CEA 97 1.1 (1.0)
ICA/CCA ratios Contralateral side
Randomisation N Mean (SD) Mean diff. 95% CI
Pre-intervention CAS 129 2.1 (2.5) 0.04 (0.64 to 0.57)
CEA 125 2.1 (2.4)
30 days follow-up CAS 129 1.9 (2.2) 0.06 (0.64 to 0.51)
CEA 120 1.9 (2.4)
1 year follow-up CAS 122 1.9 (2.3) 0.19 (0.34 to 0.73)
CEA 113 1.8 (1.8)
2 years follow-up CAS 109 1.9 (2.2) 0.10 (0.50 to 0.69)
CEA 96 1.8 (2.2)
Mean difference reﬂects the difference between ICC/CCA ratio pre-procedurally and ICA/CCA ratio at time of follow-up.
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CAS while there were no changes among those who had
CEA. This ﬁnding suggests some progressive arterial nar-
rowing at the site of the CAS during follow-up.
We found a statistically signiﬁcant increase in ICA/ICC
ratios following CAS compared with CEA during follow-up.
Because of the fact that we could not validate our results
with conventional angiography and due to the lack ofFigure 2. KaplaneMeier estimates for restenosis of the ipsilateral
ICA, CAS vs. CEA. (N ¼ 254). Time schedule: 30 dayse1 yeare2
years. p ¼ 0.012. CAS: 1.6%e22.3%e32.6%. CEA: 0.9%e8.4%e
17.1%.angiographic data during follow-up we used the same
threshold for rating restenosis in both procedures.
Conventional angiography for diagnostic or study purposes
only is, to our opinion, not ethical anymore, due to the
small but non-negligible rate of complications. Because we
found a relatively low number of patients with restenosis,
and these stenosis were often mild, we assume the problem
of different PSVs and therefore cut-offs in this cohort will beFigure 3. KaplaneMeier estimates for stenosis of the contralateral
ICA, CAS vs. CEA. (N ¼ 253). Time schedule, 30 dayse1 yeare2
years. p¼ 0.766. CAS: 29.5%e31.3%e35.9%e41.3%. CEA: 29.8%e
30.6%e34.8%e39.8%.
B.L. Reichmann et al. 559relatively small. Based on the very same DUS thresholds
applied for follow-up after both CAS and CEA, the rate of
apparent restenosis in our population was higher following
CAS.
Several studies have reported long-term follow-up results
in which a higher rate of restenosis was seen in patients
treated by CAS compared with patients treated by
CEA.4,11,12 It has to be noted that most patients in the
endovascular arm of the Carotid and Vertebral Artery
Transluminal Angioplasty Study (CAVATAS) trial had angio-
plasty without stenting and thus might be more susceptible
to restenosis. In the SPACE trial, the incidence of >70%
recurrent carotid stenosis at 2 years, as deﬁned by DUS, was
signiﬁcantly higher (up to 10.7%) after CAS.4
Rates of in-stent restenosis may be overestimated when
the conventional ultrasound criteria are applied.13 As
a consequence, there is still no consensus on DUS grading
of carotid in-stent restenosis. We could not validate our
results with conventional angiography due to the lack of
angiographic data during follow-up; conventional angiog-
raphy for diagnostic or study purposes only is not ethical
anymore, due to the small but non-negligible rate of
complications associated with conventional angiography. In
previous reports after CAS, the accepted velocity criteria for
native carotid arteries classiﬁed angiographically normal
stented arteries as being stenotic and this discrepancy may
persist into the follow-up period. Moreover, these studies
found relatively increased PSV values following CAS in the
absence of restenosis, suggesting that the PSV threshold for
detecting in-stent restenosis 50% might be higher than
125 cm s1 for restenosis detection in the surgically treated
carotid.13,14 It has to be noted that all these studies were
cross-sectional analyses and no natural follow-up data were
collected concerning the development of PSVICA over time.
Furthermore, criteria calculated from these data may suffer
from veriﬁcation bias. Veriﬁcation bias is introduced if the
decision to perform the reference standard procedure
depends on the results of the test under investigation,
precluding a reliable estimate of the diagnostic accuracy of
the latter.15 A diagnostic study has started with the aim to
validate the use of DUS for in-stent stenosis measurements
during follow-up after CAS and to determine reliable cut-off
criteria for the different degrees of stenosis.8 In this study
all patients will have the very same imaging protocol with
DUS and CTA during follow-up to prevent validation bias.
Some authors indicated that DUS should be performed
directly after revascularisation to evaluate PSVs and diam-
eter of the treated vessel at baseline in order to be able to
determine a standard for these parameters during follow-
up.16 In the present study, our primary goal was to compare
the natural changes in ﬂow velocities following both
procedures during follow-up, independent of whether these
changes represent an apparent restenosis of 50%.
Therefore, the use of the very same DUS velocity criteria
following both CAS and CEA was essential to quantify the
haemodynamic changes in the revascularised segment
between both procedures over time. Whether CAS indeed
more frequently leads to the development ofhaemodynamic relevant restenosis needs to be evaluated in
a larger cohort, with conﬁrmation of a protocolised refer-
ence test such as CTA in all subjects.
As an alternative to the PSVICA, the ICA/CCA ratio may
also be used as a measure to grade (re)stenosis. Some
authors have stated that progressively increasing PSVICA and
ICA/CCA ratios correlate with evolving restenosis within the
stented carotid artery.17 We observed signiﬁcant changes in
ICA/CCA ratios following both procedures with a decrease
from approximately 5.6 to about 1.2 for both procedures
after 30 days. During further follow-up the ratio increased
signiﬁcantly more following CAS (up to 1.5) compared with
CEA (1.1) after 2 years of follow-up.
In an analysis on postoperative morphological and hae-
modynamic conditions following carotid revascularisation
with either CAS or CEA a signiﬁcant decrease in PSVICA,
mean peak velocity (Vmean) and end diastolic velocity (EDV)
was observed in favour of CEA compared with CAS (PSVICA
following CAS of 80  25 cm s1 and 53  17 cm s1
following CEA).18 Follow-up, however, was limited to 30
days.
Normal baseline PSVICA values in the non-atherosclerotic
ICA were found to be 58  11 cm s1 in an average
European population.19 When compared to ﬂow velocities
in healthy individuals our ﬁndings still showed a higher
PSVICA post intervention. A possible explanation for this
relative post-CEA and post-CAS increase in PSVICA is the
altered compliance of the arterial wall post intervention.
Placing a stent in the arterial lumen compresses plaque
against the arterial wall. This may alter the ability of the
artery to expand and contract and therefore change its
overall biomechanical properties.20,21 Consequently, this
may cause an increase in ﬂow velocities. The type of stent is
an independent factor inﬂuencing the velocities following
carotid stenting. Self-expendable stents will steadily
increase over time and increase the diameter of the carotid
artery for up to 3 months.22 When patients are examined 30
days after the procedure the carotid artery (and stent)
might have not reached their maximum expansion yet and
therefore ﬂow velocities might not be at their lowest value
after the intervention. Different stent types do have
different physical properties and may consequently lead to
different PSVICA values following stenting even in the
absence of any residual or in-stent stenosis.23 This differ-
ence in stent design could also result in different haemo-
dynamic properties and therefore their indirect effect on
ﬂow velocities and branch patency remains speculative. Our
sample size was too small to analyse the effects of different
stent types.STUDY LIMITATIONS
A limitation of this study is the relatively limited sample size
based on single-centre results. The single-centre approach
using analyses from a single vascular laboratory otherwise
makes our comparison between two different techniques
more reliable. Due to the lack of well-deﬁned and generally
accepted duplex criteria for grading stenosis in the ICA in
560 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 6 June/2013stented arteries, we chose to apply the very same and
predeﬁned velocity threshold to compare both revascular-
isation procedures. While this cut-off point remains arbi-
trary, by using one and the same cut-off value, in our
opinion, it can be used to compare the natural pattern and
differences in blood ﬂow velocities between both proce-
dures. In order to get deﬁnitive evidence on ICA haemo-
dynamics following carotid revascularisation and its clinical
long-term clinical impact further follow-up has to be awai-
ted. Our relatively small sample size impedes any conclu-
sions about differences in changes in PSV with different
stent types. Data on ﬂow velocities and different stent types
in ICSS as a whole have to be awaited in order to analyse
these differences.
CONCLUSION
There is no interprocedural difference in changes of PSVICA
between CAS and CEA. The progression of the PSVICA
following CAS seems an ongoing phenomenon while PSVICA
in post-CEA patients remains stable over time. We observed
signiﬁcantly higher ICA/CCA ratios following CAS as
compared with CEA. These observations indicate that the 2-
year rate of apparent restenosis following CAS might be
higher compared with CEA. Further research concerning
accurately grading in-stent restenosis is needed to evaluate
ongoing haemodynamic changes and its clinical impact in
patients treated by CAS for stenotic carotid disease.
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